Composition
-
Each film-coated tablet contains: Atovaquone IP 250mg
Indications
-
Babesia gibsoni
-
Toxoplasmosis
-
Pneumocystis infections
Benefits
-
Targeted treatment for protozoal parasites affecting pets.
-
Proven mechanism: Inhibits mitochondrial respiration in Babesia and Toxoplasma species.
-
Tablet form ensures convenience for larger dogs and easy dosing during longer treatment regimens.
-
Reliable for chronic infections and ideal for long-term care protocols.
-
Veterinary-grade safety and efficacy with consistent performance.
Dosage & Administration
-
Dosage: 13.3–15 mg/kg every 8 hours for 10 days.
-
Use strictly as per professional veterinary advice.
-
Never self-administer or change dosage frequency without expert guidance.
-
Directions for Use: Administer orally as per body weight and dosing schedule directed by a pet expert. Ensure the full course is completed.
Storage
-
Store in a cool, dry place away from direct sunlight.
-
Keep out of reach of children and animals.